Trials / Completed
CompletedNCT00195793
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
A Multicenter, Randomized, Double-Blind, Prospective, Parallel Study to Compare the Safety and Efficacy of Fenofibrate or Ezetimibe as Add-On Therapy to Atorvastatin in Subjects With Combined Hyperlipidemia, Typical of the Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the effects of adding Tricor 145 mg to once daily atorvastatin 20 mg on CHD lipid laboratory parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fenofibrate | |
| DRUG | ezetimibe | |
| DRUG | atorvastatin |
Timeline
- Start date
- 2004-08-01
- First posted
- 2005-09-20
- Last updated
- 2007-10-04
Source: ClinicalTrials.gov record NCT00195793. Inclusion in this directory is not an endorsement.